Meredith Wadman · 2017

The Vaccine Race

Science, Politics, and the Human Costs of Defeating Disease

Rough AI truth score

92/100

Its medical core is strong: congenital rubella was devastating, WI-38 enabled reliable vaccine work, and RA 27/3 became the dominant strain. Its ethical critique is also well grounded, though practices varied.

Based on three central claims · high confidence

The three claims

01Supported

The 1964–65 rubella epidemic caused a large burden of fetal death and congenital blindness, deafness, heart disease, and developmental disability.

CDC estimates for the U.S. epidemic include 12.5 million infections, thousands of fetal and neonatal deaths, and roughly 20,000 infants born with congenital rubella syndrome. Maternal infection early in pregnancy carries the greatest fetal risk.

CDC: Elimination of Rubella and Congenital Rubella Syndrome CDC surveillance manual: Congenital Rubella Syndrome

02Supported

Leonard Hayflick's WI-38 human diploid cell strain enabled safer, standardized viral-vaccine production and Stanley Plotkin's RA 27/3 rubella vaccine.

WI-38 offered well-characterized normal human cells without the contamination problems of some primary animal cultures. Plotkin attenuated RA 27/3 in WI-38; that strain became the predominant rubella vaccine and remains part of MMR programs.

The Role of the WI-38 Cell Strain in Saving Lives NCBI: Histories of Pertussis and Rubella Vaccines

03Mostly supported

Rubella-vaccine development exposed weak consent practices, institutional rivalry, and conflicts over ownership and commercialization in mid-century biomedicine.

The fetal tissue behind WI-38 was obtained without modern informed consent, and trials included institutionalized children under standards now judged inadequate. NIH, Wistar, manufacturers, and researchers also disputed preferred strains and control; the details resist one villain.

National Network of Libraries of Medicine: The Vaccine Race The Role of the WI-38 Cell Strain in Saving Lives

Other claims worth checking

The Hayflick limit changed ideas about cellular aging.
Regulatory institutions sometimes favored locally controlled technologies over technically stronger competitors.

What this number means. It is an AI-generated first-pass judgment of three central factual or causal claims—not a rating, exhaustive fact-check, or human peer review. Claim credits are 100% for supported, 75% for mostly supported, 50% for mixed, and 25% for weak, then averaged and rounded. Lower confidence means the score should move more as better evidence arrives.

Method three-central-claims/0.1.0 · checked 2026-09-01 · 3/3 selected claims assessed · method and source audit